WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 6'7201 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 17'6151 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 9'357  9'405  9'450  9'491  9'526  9'981  10'260  9'659 
Births 103  103  104  104  103  88  143  157 
Surviving infants 102  103  103  103  102  87  141  154 
Pop. less than 5 years 521  526  523  509  500  461  807  745 
Pop. less than 15 years 1'432  1'423  1'416  1'409  1'415  1'861  2'367  2'210 
Female 15-49 years 2'343  2'382  2'421  2'459  2'496  2'637  2'482  2'502 

Number of reported case

(Click for retrospective incidence data for Belarus)
Diphtheria 52  22 
Japanese encephalitis
Measles 16  10  50  21  224 
Mumps 61  48  88  172  19'069 
Pertussis 188  576  151  112  93  169  462 
Polio*
Rubella 10  20  16'034 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Belarus)
Vaccine year result method % card seen                                                
BCG          99  98  99  99  98  99 
DTP1          99  99  99  97  98 
DTP3          98  98  99  98  97  99 
HepB_BD          99  98  98  98  98 
HepB3          98  97  98  96  98  70 
Hib3          98  99  100  93  96 
JapEnc         
MCV          99  98  99  99  99  98 
MCV2          99  97  99  99  99  92 
PCV1         
PCV3         
Pol3          98  98  99  99  99  99 
Rota1         
Rota_last         
Rubella1          99  98  99  99  99 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Belarus)
BCG 99  98  99  99  98  99 
DTP1 99  98  99  99  98  99 
DTP3 98  98  98  98  96  99 
HepB3 98  97  98  96  98  70 
HepB_BD 99  98  98  98  98 
Hib3 23  22  21  19 
MCV 99  98  99  99  99  98 
MCV2 99  97  99  99  99  92 
PCV3
Pol3 98  98  98  99  98  99 
Rota_last

Number of districts in the country 131  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 92
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
8
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; Yes
DT 6 years; Yes
DTaPHibIPV 3, 4, 5, 18 months; No
DTaPIPV 3, 4, 5,18 months; No
DTwP 3, 4, 5, 18 months; Yes
HepB 1 day; 1, 5 months; Yes and HCW
IPV 3, 4, 5 months; Yes
Influenza Yes high risk groups
MMR 12 months; 6 years; Yes
OPV 18, 24 months; 7 years; Yes
TT No emergencies prophzlactics
Td 16, 26, 36, 46, 56, 66 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number   2007-2012  2007-2012  2007-2012  2007-2012  2007-2012   
Nº of districts with microplans that include activities to raise immunization coverage number   121          119 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 131  121  130  130  119  119  119 
Nº districts with DTP3 coverage >=80% number 121  121  130  130  119  119 
% of districts with DTP3 coverage >=80% From 0 to 100% 92  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 121  121  130  130  119  119   
% of districts with MCV1 coverage >=95% From 0 to 100% 92  100  100  100  100  100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 65  47  NA  NA  75  75  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.